本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Krystal Biotech Inc.

139.47
-22.8200-14.06%
盘后139.710.2400+0.17%18:01 EDT
成交量:133.33万
成交额:1.86亿
市值:40.30亿
市盈率:46.49
高:145.25
开:143.01
低:135.00
收:162.29
数据加载中...
2024/08/28

重要事件披露

Form 8-K - Current report
2024/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/05

重要事件披露

Form 8-K - Current report
2024/07/10

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/21

重要事件披露

Form 8-K - Current report
2024/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]